The move to value-based payment is going well, but the real work has to be done on the care transformation side, Farzad Mostashari, MD, co-founder and chief executive of Aledade.
The move to value-based payment is going well, but the real work has to be done on the care transformation side, Farzad Mostashari, MD, co-founder and chief executive of Aledade, said at the National Association of Accountable Care Organizations Spring 2016 Conference in Baltimore, Maryland.
Transcript (slightly modified)
How do you think the move to value-based payments is going so far?
Look, the move to value-based payment is going great. The delivery transformation to meet the new payment models is where I think we have a lot of work to do.
There’s been a massive increase in the number of accountable care contracts—those on the Medicare side, those on the commercial side, and there isn’t a single payer that we’ve talked who hasn’t said “sure, yeah, we’re interested in a risk-based contract.” The challenge is just having a new payment model doesn’t automatically guarantee that you’re going to have care transformation. The real work that has to be done is on the care transformation side.
Do you think accountable care organizations (ACOs) are here to stay?
I do, I do think ACOs are here to stay. If we’re able to actually create better care at lower costs.
In this new volume to value transition, I said there are 3 options for business models. Option 1: Deliver better care at lower costs. It’s hard. Option 2: Create or support a local monopoly. Then you don’t need to deliver better care at lower costs, right? You just have a monopoly; monopolies are awesome in that way! And hope that the Department of Justice and the Federal Trade Commission, you know, don’t pick up on this. Option 3 is close your doors.
So we’re choosing option 1.
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
What We’re Reading: HHS' Funding Flat; Mifepristone Safety; Insulin Shortage
March 25th 2024Flat funding for Health and Human Services (HHS) leaves critical health initiatives stagnant; Supreme Court weighs tightening regulations on abortion pill; manufacturing delay sparks access concerns for insulin medication.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Health Equity and Access Weekly Roundup: March 23, 2024
March 23rd 2024The Center on Health Equity and Access covered disparities in hypertension, diabetic eye health, and hidradenitis suppurativa, along with the proposed legislation banning diversity, equity, and inclusion efforts in Alabama schools and the consequences in sickle cell care from the CDC guideline for opioid prescriptions.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More